Here Are the Best and Worst Biopharma Stock Performers So Far This Year

Retrieved on: 2021-06-30 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Here Are the Best and Worst Biopharma Stock Performers So Far This Year. View article details on hiswai:

Excerpt

The company developed bamlanivimab, one of the monoclonal antibodies in the Covid-19 antibody cocktail marketed by Eli Lilly (LLY). Expectations ...

Article found on: www.barrons.com